We are live on ! Find out more
BCM

Blume Capital Management Portfolio holdings

AUM $684M
1-Year Est. Return 41.68%
This Fund
S&P 500
This Quarter Est. Return
+4.7%
1 Year Est. Return
+41.68%
3 Year Est. Return
+96.87%
5 Year Est. Return
+108.87%
10 Year Est. Return
+366.52%
AUM
$173M
AUM Growth
+$6.38M
Cap. Flow
-$313K
Cap. Flow %
-0.18%
Top 10 Hldgs %
45.77%
Holding
228
New
18
Increased
30
Reduced
55
Closed
21

Top Buys

Rank Stock Value
1
RRC icon
Range Resources
RRC
+$2.87M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$872K
3
GE icon
GE Aerospace
GE
+$759K
4
VTEB icon
Vanguard Tax-Exempt Bond Index Fund
VTEB
+$554K
5
KMI icon
Kinder Morgan
KMI
+$404K

Top Sells

Rank Stock Value
1
TWX
Time Warner Inc
TWX
+$3.33M
2
AR icon
Antero Resources
AR
+$1.48M
3
JPM icon
JPMorgan Chase
JPM
+$878K
4
MSFT icon
Microsoft
MSFT
+$497K
5
EMR icon
Emerson Electric
EMR
+$376K

Sector Composition

Rank Sector Weight
1 Technology 19.33%
2 Energy 17.72%
3 Financials 13.66%
4 Healthcare 13.44%
5 Communication Services 9.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GSK icon
151
GSK
GSK
$104B
$12K 0.01%
226
– –
DNP icon
152
DNP Select Income Fund
DNP
$4.05B
$11K 0.01%
1,000
– –
OKS
153
DELISTED
Oneok Partners LP
OKS
$11K 0.01%
200
– –
ARCC icon
154
Ares Capital
ARCC
$13.5B
$9K 0.01%
500
-300
-38% -$5.18K
P
155
DELISTED
Pandora Media Inc
P
$9K 0.01%
750
– –
BF.A icon
156
Brown-Forman Class A
BF.A
$13.4B
$8K ﹤0.01%
200
– –
BOX icon
157
Box
BOX
$4.37B
$8K ﹤0.01%
+500
New +$8.45K
CORT icon
158
Corcept Therapeutics
CORT
$12.4B
$8K ﹤0.01%
700
– –
NVCR icon
159
NovoCure
NVCR
$1.73B
$8K ﹤0.01%
1,000
– –
TTNP
160
DELISTED
Titan Pharmaceuticals
TTNP
$8K ﹤0.01%
1
– –
UDR icon
161
UDR
UDR
$12.3B
$8K ﹤0.01%
216
– –
WY icon
162
Weyerhaeuser
WY
$18B
$8K ﹤0.01%
246
-50
-17% -$1.63K
EFA icon
163
iShares MSCI EAFE ETF
EFA
$78B
$7K ﹤0.01%
+116
New +$7.01K
INO icon
164
Inovio Pharmaceuticals
INO
$55.7M
$7K ﹤0.01%
83
– –
KIM icon
165
Kimco Realty
KIM
$17.2B
$7K ﹤0.01%
300
– –
RWT
166
Redwood Trust
RWT
$574M
$7K ﹤0.01%
448
– –
XBI icon
167
State Street SPDR S&P Biotech ETF
XBI
$9.95B
$7K ﹤0.01%
105
– –
CLB icon
168
Core Laboratories
CLB
$488M
$6K ﹤0.01%
50
– –
DRRX
169
DELISTED
DURECT Corp
DRRX
$6K ﹤0.01%
600
– –
B
170
Barrick Mining
B
$61.5B
$6K ﹤0.01%
300
– –
MGK icon
171
Vanguard Morningstar Mega Cap Growth ETF
MGK
$32.5B
$6K ﹤0.01%
300
– –
NKE icon
172
Nike
NKE
$61.9B
$6K ﹤0.01%
100
– –
VCV icon
173
Invesco California Value Municipal Income Trust
VCV
$518M
$6K ﹤0.01%
500
– –
TWTR
174
DELISTED
Twitter, Inc.
TWTR
$6K ﹤0.01%
400
– –
FIT
175
DELISTED
Fitbit, Inc. Class A common stock
FIT
$6K ﹤0.01%
1,000
-2,800
-74% -$17.8K
5 6
7
8 9

Similar funds

HCP
Hexagon Capital Partners Rogers, Arkansas $683M AUM 34.85% 1-Year Est. Return
TWM
Tolleson Wealth Management Dallas, Texas $685M AUM 15.32% 1-Year Est. Return
HWM
Horizon Wealth Management La Grange, Illinois $682M AUM 25.04% 1-Year Est. Return
ECM
Estabrook Capital Management New York $685M AUM 26.64% 1-Year Est. Return
DMC
Drexel Morgan & Co Radnor, Pennsylvania $682M AUM 21.01% 1-Year Est. Return
NS
Night Squared New York $681M AUM 50% 1-Year Est. Return
CIA
Covington Investment Advisors Ligonier, Pennsylvania $680M AUM 28.91% 1-Year Est. Return
CCG
Clearlake Capital Group Santa Monica, California $680M AUM 30.34% 1-Year Est. Return

Blume Capital Management's Q1 2017 Portfolio in Review

As of Q1 2017, Blume Capital Management held 228 positions worth $173M, up 3.8% from $166M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Blume Capital Management's Q1 2017 filing shows 18 new, 30 increased, 55 reduced and 21 closed positions. Its largest new stake was Range Resources: 92,850 shares worth $2.7M. The largest sale was Time Warner Inc, an estimated $3.33M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Energy and Financials.

  • Blume Capital Management's largest Q1 2017 buy was Range Resources: 92,850 shares worth $2.7M.
  • Blume Capital Management added most to Teva Pharmaceuticals in Q1 2017, an estimated $872K increase.
  • Blume Capital Management's biggest Q1 2017 reduction was Antero Resources, cutting an estimated $1.48M.
  • Blume Capital Management fully exited Time Warner Inc in Q1 2017, selling an estimated $3.33M.
  • Blume Capital Management's ten largest holdings make up 46% of its $173M portfolio in Q1 2017.
  • Blume Capital Management opened 18 new positions and closed 21 in Q1 2017.
  • Blume Capital Management's portfolio value rose 3.8% quarter-over-quarter to $173M.

Based on Blume Capital Management's 13F filing for Q1 2017, filed 12 May 2017.